The presence of genetic mutations in HIV poses a significant challenge,
potentially leading to antiretroviral resistance and hampering therapeutic
development. The Brazilian population has presented variations in the HIV
envelope V3 loop gene, especially the GWGR motif. This motif has been linked to
reduced transmission potential and slower CD4+ T cell decline. This study aimed
to assess clinical outcomes in patients with HIV-1 infected with strains
containing the GWGR motif compared with those without it during long-term cART.
A cohort of 295 patients with HIV was examined for the GWGR motif presence in
the V3 loop. A total of 58 samples showed the GWGR signature, while 237 had
other signatures. Multifactorial analyses showed no significant differences in
demographic characteristics, CD4+ cell count, AIDS progression, or mortality
between GWGR carriers and others. However, the mean interval between the first
positive HIV test and the initial AIDS-defining event was more than two times
longer for women carrying the GWGR signature (p = 0.0231). We emphasize the
positive impact of cART on HIV/AIDS treatment, including viral suppression, CD4+
cell preservation, and immune function maintenance. Although no significant
differences were found during cART, residual outcomes reflecting adherence
challenges were observed between diagnosis and the first AIDS-defining event.
The previously described outcomes, highlighting statistically significant
differences between individuals carrying the GPGR motif compared with those with
the Brazilian GWGR motif, may be directly linked to the natural progression of
infection before advancements in cART. Presently, these physicochemical aspects
may no longer hold the same relevance.